This investigate was carried out to evaluate the potential of the CPPs with tumor-targeting Qualities to deliver a cytotoxic payload to HCC cells. We explored using a CXCR4-concentrating on peptide, T22, fused with cytotoxic peptide PE24, like a novel therapeutic system for CXCR4+ HCC cells. T22 was selected as the https://ewartk754otx7.wikikali.com/user